• Open Account

Shukra Pharmaceuticals Ltd

Small Cap  | Pharmaceuticals
₹ 66.94 0.16(0.24%)
Last updated: 09-Oct-2026 , 15:54:25
Shukra Pharmaceuticals Ltd Price Today Shukra Pharmaceuticals Ltd share price is ₹66.94 as on 09-Oct-2026, Up 0.24% from the previous close of ₹66.78. The stock has traded between ₹69.45 and ₹66.74 today, against a 52-week range of ₹40.06 to ₹75.4. Over the past year the stock is Up 88.22% range. Market capitalisation stands at ₹3029.95 crore.

Shukra Pharmaceuticals Ltd Live Price Chart

Performance

Low: ₹66.74 High: 69.45
Previous Close ₹ 66.78
High ₹ 69.45
Volume 4237781
52W Range ₹ 40.06 - ₹ 75.4
Open ₹ 67.7
Low ₹ 66.74
Market Cap ₹ 3029.95 Cr

Shukra Pharmaceuticals Ltd Technicals

Current Price
₹ 66.94 0.16 (0.24%)
EMASMA
20 Day ₹ 60.672
50 Day ₹ 51.984
100 Day ₹ 45.292
200 Day ₹ 40.274
20 Day ₹ 59.960
50 Day ₹ 49.333
100 Day ₹ 40.123
200 Day ₹ 40.512

Shukra Pharmaceuticals Ltd Fundamentals

ROCE 31.449
P/E Ratio 82.700
P/B Ratio 29.360
Industry P/E 29.360
Debt to Equity 49.304
ROE 24.543
EPS 0.810
Dividend Yield 0.010
Book Value 2.281
Face Value 1.000

Shukra Pharmaceuticals Ltd Financials

Particulars Y202603 Y202503 Y202403 Y202303 Y202203
Total Revenue 61.291 36.794 77.3881 60.0304 20.567
Total Expenses 32.5181 23.4573 57.5048 55.5887 19.549
Profit After Tax 22.0479 9.5751 18.5372 4.4065 0.7507

Shukra Pharmaceuticals Ltd Shareholding Pattern

Promoter Holdings 51.152 %
FIIs 0.003 %
DIIs 0.114 %
MutualFund 0.000 %
Retail 9.339 %
Others - 39.392 %

About Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Limited, formerly known Relish Pharmaceuticals Limited was established in March, 1993. The Company changed the name to the present i.e. Shukra Pharmaceuticals Limited on September 22, 2016. The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others. The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat. The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc. The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world. In FY 2013-14, the Company got approval from ...

Similar Stocks

Ambalal Sarabhai Enterprises Ltd Pharmaceuticals ₹ 40.59
+0.32 (+0.79%)
Amrutanjan Health Care Ltd Pharmaceuticals ₹ 508.90
+5.85 (+1.16%)
Astrazeneca Pharma India Ltd Pharmaceuticals ₹ 5,837.00
+117.5 (+2.05%)
Bliss GVS Pharma Ltd Pharmaceuticals ₹ 655.95
-11.75 (-1.76%)
Abbott India Ltd Pharmaceuticals ₹ 26,000.00
+420 (+1.64%)
Cipla Ltd Pharmaceuticals ₹ 1,301.00
-5.8 (-0.44%)

FAQs on Shukra Pharmaceuticals Ltd

1. Can I buy Shukra Pharmaceuticals Ltd from PL Capital? ›

Yes, you can invest in Shukra Pharmaceuticals Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Shukra Pharmaceuticals Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Shukra Pharmaceuticals Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Shukra Pharmaceuticals Ltd pay dividends? ›

Yes, Shukra Pharmaceuticals Ltd has a consistent history of rewarding its shareholders through dividend payouts. Dividend frequency and amounts vary depending on the company’s financial performance and board approvals. Investors holding Shukra Pharmaceuticals Ltd shares on the record date announced by the company are eligible to receive dividends directly into their bank accounts linked with their Demat holdings.

3. What is the current share price of Shukra Pharmaceuticals Ltd ? ›

As of 09-Oct-2026 , 15:54:25 the share price for Shukra Pharmaceuticals Ltd. is ₹ 66.94 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Shukra Pharmaceuticals Ltd ? ›

The 52-week high and low of Shukra Pharmaceuticals Ltd share price is ₹ 40.06 - ₹ 75.4 as of 09-Oct-2026 , 15:54:25 .

5. What is the market capitalisation of Shukra Pharmaceuticals Ltd? ›

Market capitalisation of Shukra Pharmaceuticals Ltd is ₹3029.95Cr as of 09-Oct-2026.

6. What is the current P/E ratio of Shukra Pharmaceuticals Ltd? ›

The P/E (price-to-earnings) ratio of Shukra Pharmaceuticals Ltd is 82.700.

7. What is the current P/B ratio of Shukra Pharmaceuticals Ltd? ›

The P/B (price-to-book) ratio of Shukra Pharmaceuticals Ltd is 29.360.

8. What is the shareholding pattern of Shukra Pharmaceuticals Ltd? ›

As of 09-Oct-2026, promoters hold 51.152%, foreign institutional investors hold 0.003%, domestic institutional investors hold 0.114%, and the public holds 9.339%.

9. What is the 1-year return of Shukra Pharmaceuticals Ltd? ›

The 1-year return of Shukra Pharmaceuticals Ltd is + 88.22%.
Open Your Demat Account
with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges
Start Stock SIP

Start SIP in Shukra Pharmaceuticals Ltd

Invest systematically in stocks with the
PL Capital app

Get the App
Start SIP mobile app preview
App QR Code

Download the PL Capital App

Open Demat Account
×
I consent to receive calls/messages from PL